Travis Parigi, CEO of LiquidFrameworks, is excited about the new doors that have been opened for his company. Courtesy of LiquidFrameworks

Travis Parigi has built his software within his own company for about 14 years. Now, he's in a position to further develop his product at a faster rate.

In January, LiquidFrameworks entered into a partnership with private equity firm, Luminate Capital. The new financial partner has opened doors for Parigi and LiquidFrameworks — including putting merger and acquisition activity on the table.

"I have historically written stuff from the ground up, and we're going to continue to do that, but we want to give our customers more than that," Parigi tells InnovationMap. "And I've never had the opportunity to go out and strategically target opportunities where it makes sense to compliment the product. And I think that's going to be a very exciting thing to do."

Parigi, founder and CEO, tells InnovationMap about how his company has transformed over the years — and especially over the past several months with its new financial backer.

InnovationMap: How did you get your start in software development?

Travis Parigi: I've been building software since I was a very young kid, actually. I started writing software for companies at a very early age and realized that I really, really enjoyed it. And so when I say young, I'm talking in grade school and high school. And I really found that it was rewarding and I enjoyed meeting the requirements that people gave me. From the very early days, I knew I wanted to start a software company, but I really wasn't sure exactly what it would do. I went to work in the consulting industry right after graduating from A&M University with a degree in computer science and engineering and was building software for variety of different companies that were their clients and started to get some exposure to the energy industry.

Then in the late 1990s, the company I was at was going through some financial struggles, and it became an opportune time for me to start my own consulting company building software for companies. One client I had was Schlumberger, and I really started seeing this similar business problem related to collecting data at the well site. The workers in the field were working with paper and Excel. I thought it was a great opportunity to move people out of manual and into the digital world.

IM: Now, over a decade later, what role do you feel LiquidFrameworks plays in the industry?

TP: We play a role of standardizing the datasets that our clients are working with as it relates to the quote to cash process. So, specifically around their pricing data and their catalog data. We're standardizing that data and we're getting it into form and a shape that allows them to easily keep it up to date and easily syndicated changes related to that data out to not only other offices and districts, but also field crew that may be occasionally connected to the network.

With that data, we can do all sorts of things that end up benefiting the customer — like using it to create field tickets, invoices, work orders, safety forms, quotes, and all sorts of transactions that really need to be based upon one homogenous set of data that standardize, that isn't floating around in various documents.

IM: Where does the artificial intelligence LiquidFrameworks has developed come into play?

TP: We're taking it one step further, and once they finished those transactions, they end up with not just the reference data as it relates to pricing, but also the transactional data, we can use that data to infer the best way to quote or price new services in the future that will position the company and the best possible place to win the deals that they're quoting and bidding against. We're using different types of artificial intelligence algorithms to do that.

Nowadays, companies like us have at our disposal tools in the AI world — specifically in the machine learning world — that we just didn't have when I started the company. Fourteen years ago when I started the business, cloud computing in 2005 was not nearly as ubiquitous as it is today. And it wasn't as widely accepted and it certainly wasn't as widely accepted as it is in the energy industry today.

IM: What kind of clients are you working with?

TP: We're targeting three different industries. The upstream oil and gas service provider market, the downstream service provider market, and the emergency response service provider market. On the upstream side, they are companies doing work at the well site, and in downstream, they are companies doing work at the refineries.

IM: As automation and cloud technology is being more adapted within oil and gas, what technologies are now on your radar?

TP: In the beginning, we spent a lot of time educating our potential customers about cloud computing and about technologies that we had available. And now that a lot of that is so well received, it just means that we don't necessarily have to focus on that anymore. We can focus really on what really brings ROI to the customers that implement our product.

I keep a keen watch on a lot of the different technologies that are emerging out there. Blockchain is certainly one of them that we're looking at. I think there's some interesting things that we might be able to do with that as it relates to price book management, which is complex and varied. It could be that blockchain could end up providing a nice mechanism for both parties to independently have pricing data verified.

We're always keeping an eye on and doing work in artificial intelligence, specifically around machine learning. I think there's always new interesting stuff taking place there outside. I would say those two technologies are something that we're pretty pretty keen on.

IM: How has the transition into private equity been with your new partner in Silicon Valley-based Luminate Capital?

TP: We had a financial partner prior to Luminate Capital called Houston Ventures. Our managing partner there was a guy named Chip Davis. He was fantastic, and he helped us grow the business for about seven years. Eventually, we got to a point where we had grown to a level where I felt like, in order to do some things we wanted to do, we needed to establish a new financial partner. Private equity made the most sense for us, and it's really allowing us to do some things that we couldn't do with venture.

Over the years, we built out a fairly extensive roadmap, and my development team has worked very hard and diligently to fulfill those items on the roadmap. But our customer base has really grown significantly, and we've moved up into enterprise customers who have asked for a lot of things that we want to put into our product. And so our long range roadmap has grown. For these new features, we either need to build that ourselves in house, but, in some cases, there are some things that are tangential and complimentary to our product that other companies have already. So, it could make sense for us to go out and acquire those kinds of companies. And with Luminate, they provided us not only capital for us to do that, but equally as important, they provided an engine that we can facilitate from an M&A perspective to help us go and source those deals, find them, help assess them, and ultimately help acquire them and then integrate them into the overall platform.

IM: How has the partnership benefitted your company from a networking and opportunities perspective?

TP: Their portfolio of companies are similar to us and that they're are all enterprise software companies. They're not necessarily in the energy space, but they're all enterprise software companies. Being able to network with those companies has really been helpful. We didn't have a CFO prior to Luminate coming in. Part of the deal was that they said, "hey, we really would encourage and recommend that you get a CFO at this stage because you're growing and you need it." They provided some relationships there to in the form of recruiters to help us source the CFO. And we ended up sourcing a local CFO — Paul Marvin — who's absolutely fantastic.

IM: How has Houston been as a home base for you?

TP: Houston has been fantastic for LiquidFrameworks. I started the business based here and see no reason to change that. It is a fantastic market for us, both from a customer perspective as well as an employee perspective. The employee talent base in Houston is rich and deep. There's a lot of technical people here, and obviously there's a ton of energy companies.

IM: With all your operations being in Houston, do you see opportunities for other offices in the future?

TP: We have customers all over the world — a lot in Canada, so I could see an office there for sales and implementation. I would say that as we grow, expanding sales to other geographies is certainly something that will ultimately end up doing. It's just not something we've had to do yet.

IM: Are you planning on growing operations here?

TP: We've added a couple dozen people to the team just over the past few months, and we plan on doubling the staff by the end of next year.

------

Portions of this interview have been edited.

Houston-based LiquidFrameworks has been acquired by San Francisco-based Luminate Capital. Pexels

Houston startup exits to Bay Area private equity firm

Grand exit

A Houston startup has entered a deal with a San Francisco-based private equity firm, the companies announced on January 10. LiquidFrameworks, which provides cloud-based, mobile field operations management solutions to oil and gas, environmental, and industrial service companies, is now operating under Luminate Capital following the acquisition.

While not all the terms of the deal have been disclosed, Chip Davis, managing partner at Houston Ventures, says the transaction exceeded $50 million of PE investment from Luminate Capital. HV has been involved with LiquidFrameworks since 2012 and has invested a cumulative $6 million, Davis says, and brought in the company's current CEO and head of sales — both of who are still a part of the company's team.

"When we got involved, it was a very small company," says Davis. "As of today, it has enterprise customers of some of the largest oilfield services companies in the world."

According to the release, Hollie Haynes, Mark Pierce, and Sanjay Palakshappa from Luminate have joined the LiquidFrameworks board of directors. The PE fund's investment is a part of the recently closed $425 million Fund II.

"For over a decade, we have served field services companies by reducing revenue leakage, shortening cash collection cycles, and increasing overall operational efficiencies. We have streamlined the day-to-day operations for field services professionals and increased transparency across organizations by transforming previously paper- or excel-based workflows," says Travis Parigi, founder and COO of LiquidFrameworks, in the release.

"With a partner like Luminate Capital, we will continue to invest and develop product capabilities to better serve field services industries that have previously been overlooked by software innovation."

One of LiquidFrameworks' tools is FieldFX, which enhances companies' data accuracy and accelerates revenue capture and cash flow.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.